2017 publications

Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.
Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher MI, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M, Mueller S, Perilongo G, Schouten-van Meeteren AYN, Tabori U, Warren K, Waanders AJ, Walker D, Weiss W, Witt O, Wright K, Zhu Y, Bowers DC, Pfister SM, Packer RJ.
Neuro Oncol. 2017 Aug 2. doi: 10.1093/neuonc/nox141. [Epub ahead of print]

Brainstem angiocentric gliomas with MYB-QKI rearrangements.
D’Aronco L, Rouleau C, Gayden T, Crevier L, D├ęcarie JC, Perreault S, Jabado N, Bandopadhayay P, Ligon KL, Ellezam B.
Acta Neuropathol. 2017 Aug 12. doi: 10.1007/s00401-017-1763-1. [Epub ahead of print] No abstract available.

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al-Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, Fangusaro J, Bandopadhayay P.
J Neurooncol. 2017 Jul 21. doi: 10.1007/s11060-017-2568-8. [Epub ahead of print]

Population Control: Cortical Interneurons Modulate Oligodendrogenesis.
Bandopadhayay P, Stiles CD.
Neuron. 2017 May 3;94(3):415-417. doi: 10.1016/j.neuron.2017.04.032.

Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
Paolella BR, Gibson WJ, Urbanski LM, Alberta JA, Zack TI, Bandopadhayay P, Nichols CA, Agarwalla PK, Brown MS, Lamothe R, Yu Y, Choi PS, Obeng EA, Heckl D, Wei G, Wang B, Tsherniak A, Vazquez F, Weir BA, Root DE, Cowley GS, Buhrlage SJ, Stiles CD, Ebert BL, Hahn WC, Reed R, Beroukhim R.
Elife. 2017 Feb 8;6. pii: e23268. doi: 10.7554/eLife.23268.

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
Ramkissoon SH, Bandopadhayay P, Hwang J, Ramkissoon LA, Greenwald NF, Schumacher SE, O’Rourke R, Pinches N, Ho P, Malkin H, Sinai C, Filbin M, Plant A, Bi WL, Chang MS, Yang E, Wright KD, Manley PE, Ducar M, Alexandrescu S, Lidov H, Delalle I, Goumnerova LC, Church AJ, Janeway KA, Harris MH, MacConaill LE, Folkerth RD, Lindeman NI, Stiles CD, Kieran MW, Ligon AH, Santagata S, Dubuc AM, Chi SN, Beroukhim R, Ligon KL.
Neuro Oncol. 2017 Jul 1;19(7):986-996. doi: 10.1093/neuonc/now294.

Pediatric low-grade gliomas: implications of the biologic era.
Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, Bowers DC, Ellison D, Fangusaro J, Foreman N, Fouladi M, Gajjar A, Haas-Kogan D, Hawkins C, Ho CY, Hwang E, Jabado N, Kilburn LB, Lassaletta A, Ligon KL, Massimino M, Meeteren SV, Mueller S, Nicolaides T, Perilongo G, Tabori U, Vezina G, Warren K, Witt O, Zhu Y, Jones DT, Kieran M.
Neuro Oncol. 2017 Jun 1;19(6):750-761. doi: 10.1093/neuonc/now209.

Tyrosine receptor kinase B is a drug target in astrocytomas.
Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ.
Neuro Oncol. 2017 Jan;19(1):22-30. doi: 10.1093/neuonc/now139. Epub 2016 Jul 10.

Comments are closed